I Peace, Inc., a Palo Alto, CA-based biotech start-up, has tripled its capacity to manufacture GMP grade iPS cells and iPSC-derived differentiated cells by expanding its facility. The facility’s expansion, designed to conform to GMP standard, is expected to start manufacturing cGMP grade cells in April this year after going through a regulatory review and FDA registration update. With this CDMO facility expansion, I Peace says it will be able to meet the growing needs for GMP iPS cells fro...